STAT

Every data point has a face: What Michael Becker taught us

Michael Becker, the patient advocate and former biotech CEO who passed away this week, urged audiences to think beyond the word “data” when talking about studies of patients.

Michael Becker was a biotech executive before he was a patient advocate. When he discovered he had head and neck cancer, he decided to go public, and in doing so made an impact — both within the drug industry and beyond.

Cancer, Becker once said, takes away a lot more than it gives. But he wanted his own experience to show people the risks of the human papillomavirus, which caused his disease,, according to the Centers for Disease Control and Prevention. In total, the HPV virus is estimated to cause 34,000 cancers annually, including cancers of the cervix and genitals.

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Cigna Biosimilar Plans, A Vertex Deal In South Africa, And More
Cigna plans to make copies of AbbVie's Humira arthritis drug available with no out-of-pocket payment to eligible patients in the U.S.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About CVS And Humira Biosimilars, Schumer’s Broken Insulin Promise, And More
New prescriptions for biosimilar versions of Humira, one of the best-selling drugs in the U.S., surged to 36% from just 5% during the first week of April.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About Biocon Eyeing Weight Loss Drugs, Sanofi Layoffs, And More
Biocon is pivoting to weight loss drugs as patents for the blockbuster medicines start to expire, unleashing a coming wave of generics.

Related Books & Audiobooks